Clinical Trials Logo

Performance Anxiety clinical trials

View clinical trials related to Performance Anxiety.

Filter by:

NCT ID: NCT03017508 Completed - Clinical trials for Social Anxiety Disorder

Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder

Start date: January 2017
Phase: Phase 2/Phase 3
Study type: Interventional

The goal of the current proposal is to examine if sublingual riluzole can reduce anxiety in people with social anxiety disorder during a public speaking task.

NCT ID: NCT02307019 Completed - Emotional Stress Clinical Trials

Intervention on Caregivers Caring for Patients Poststroke With Upper Limb Apraxia

CPA
Start date: July 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze the effects of a intervention on a specific health prevention/intervention program aimed at caregivers of mild and moderate patients post stroke with upper limb apraxia in comparison to a control group with a no specific formation in that kind of patients.

NCT ID: NCT02163148 Completed - Performance Anxiety Clinical Trials

Predictors of Exposure Success in Public Speaking Anxiety

Start date: May 2014
Phase: N/A
Study type: Observational

Anxiety disorders are common and impairing. Although exposure therapy is one of the most effective treatments for anxiety, some individuals do not fully respond to treatment, and these individual differences are not well understood. Exposure therapy involves repeated, deliberate, safe engagement with a feared stimulus without the feared outcome occurring. This treatment is thought to work through a type of emotional learning called fear extinction. This study aims to look at links between fear extinction learning and exposure success, with the overall goal of better understanding who is likely to respond best to exposure therapy and why.